Ken Minneman - Publications

Affiliations: 
Emory University, Atlanta, GA 

166 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP. High affinity ligands and potent antagonists for the α1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives. European Journal of Medicinal Chemistry. 83: 419-32. PMID 24992070 DOI: 10.1016/j.ejmech.2014.06.057  1
2011 Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP. Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes. European Journal of Medicinal Chemistry. 46: 2676-90. PMID 21514979 DOI: 10.1016/j.ejmech.2011.03.054  1
2010 Sagar S, Kaur M, Minneman KP. Antiviral lead compounds from marine sponges. Marine Drugs. 8: 2619-38. PMID 21116410 DOI: 10.3390/md8102619  1
2010 Sagar S, Kaur M, Minneman KP, Bajic VB. Anti-cancer activities of diospyrin, its derivatives and analogues. European Journal of Medicinal Chemistry. 45: 3519-30. PMID 20615584 DOI: 10.1016/j.ejmech.2010.06.021  1
2007 Bush CF, Jones SV, Lyle AN, Minneman KP, Ressler KJ, Hall RA. Specificity of olfactory receptor interactions with other G protein-coupled receptors. The Journal of Biological Chemistry. 282: 19042-51. PMID 17472961 DOI: 10.1074/jbc.M610781200  1
2007 Minneman KP. Heterodimerization and surface localization of G protein coupled receptors. Biochemical Pharmacology. 73: 1043-50. PMID 17011524 DOI: 10.1016/j.bcp.2006.09.001  1
2006 Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP. New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes. Bioorganic & Medicinal Chemistry Letters. 16: 6200-3. PMID 17027264 DOI: 10.1016/j.bmcl.2006.09.034  1
2006 Romeo G, Materia L, Pittalà V, Modica M, Salerno L, Siracusa M, Russo F, Minneman KP. New 1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives: analogues of HEAT as ligands for the alpha1-adrenergic receptor subtypes. Bioorganic & Medicinal Chemistry. 14: 5211-9. PMID 16647264 DOI: 10.1016/j.bmc.2006.04.002  1
2006 Chen Z, Hague C, Hall RA, Minneman KP. Syntrophins regulate alpha1D-adrenergic receptors through a PDZ domain-mediated interaction. The Journal of Biological Chemistry. 281: 12414-20. PMID 16533813 DOI: 10.1074/jbc.M508651200  1
2006 Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, Minneman KP. Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity. Molecular Pharmacology. 69: 45-55. PMID 16195468 DOI: 10.1124/mol.105.014985  1
2005 Chen ZJ, Minneman KP. Recent progress in alpha1-adrenergic receptor research. Acta Pharmacologica Sinica. 26: 1281-7. PMID 16225747 DOI: 10.1111/j.1745-7254.2005.00224.x  1
2005 Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR. Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. The Journal of Biological Chemistry. 280: 27289-95. PMID 15917235 DOI: 10.1074/jbc.M502365200  1
2005 Lima V, Mueller A, Kamikihara SY, Raymundi V, Alewood D, Lewis RJ, Chen Z, Minneman KP, Pupo AS. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta. European Journal of Pharmacology. 508: 183-92. PMID 15680270 DOI: 10.1016/j.ejphar.2004.12.011  1
2005 Uberti MA, Hague C, Oller H, Minneman KP, Hall RA. Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 313: 16-23. PMID 15615865 DOI: 10.1124/jpet.104.079541  1
2004 Hague C, Hall RA, Minneman KP. Olfactory receptor localization and function: an emerging role for GPCR heterodimerization. Molecular Interventions. 4: 321-2. PMID 15616160 DOI: 10.1124/mi.4.6.4  1
2004 Hague C, Uberti MA, Chen Z, Bush CF, Jones SV, Ressler KJ, Hall RA, Minneman KP. Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 13672-6. PMID 15347813 DOI: 10.1073/pnas.0403854101  1
2004 Chen Z, Rogge G, Hague C, Alewood D, Colless B, Lewis RJ, Minneman KP. Subtype-selective noncompetitive or competitive inhibition of human alpha1-adrenergic receptors by rho-TIA. The Journal of Biological Chemistry. 279: 35326-33. PMID 15194691 DOI: 10.1074/jbc.M403703200  1
2004 Hague C, Uberti MA, Chen Z, Hall RA, Minneman KP. Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors. The Journal of Biological Chemistry. 279: 15541-9. PMID 14736874 DOI: 10.1074/jbc.M314014200  1
2004 Hague C, Chen Z, Pupo AS, Schulte NA, Toews ML, Minneman KP. The N terminus of the human alpha1D-adrenergic receptor prevents cell surface expression. The Journal of Pharmacology and Experimental Therapeutics. 309: 388-97. PMID 14718583 DOI: 10.1124/jpet.103.060509  1
2004 Romeo G, Materia L, Salerno L, Russo F, Minneman KP. Novel antagonists for α1-adrenoceptor subtypes Expert Opinion On Therapeutic Patents. 14: 619-637. DOI: 10.1517/eotp.14.5.619.31271  1
2003 Uberti MA, Hall RA, Minneman KP. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Molecular Pharmacology. 64: 1379-90. PMID 14645668 DOI: 10.1124/mol.64.6.1379  1
2003 Pupo AS, Minneman KP. Specific interactions between gC1qR and alpha1-adrenoceptor subtypes. Journal of Receptor and Signal Transduction Research. 23: 185-95. PMID 14626446 DOI: 10.1081/RRS-120025200  1
2003 Hague C, Chen Z, Uberti M, Minneman KP. Alpha(1)-adrenergic receptor subtypes: non-identical triplets with different dancing partners? Life Sciences. 74: 411-8. PMID 14609720 DOI: 10.1016/j.lfs.2003.07.008  1
2003 Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes. Journal of Medicinal Chemistry. 46: 2877-94. PMID 12825930 DOI: 10.1021/jm0307741  1
2003 Lee D, Robeva A, Chen Z, Minneman KP. Mutational uncoupling of alpha1A-adrenergic receptors from G proteins also uncouples mitogenic and transcriptional responses in PC12 cells. The Journal of Pharmacology and Experimental Therapeutics. 306: 471-7. PMID 12724349 DOI: 10.1124/jpet.103.050500  1
2003 Pupo AS, Uberti MA, Minneman KP. N-terminal truncation of human alpha1D-adrenoceptors increases expression of binding sites but not protein. European Journal of Pharmacology. 462: 1-8. PMID 12591089 DOI: 10.1016/S0014-2999(03)01292-5  1
2002 Pupo AS, Minneman KP. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells. Bmc Pharmacology. 2: 17. PMID 12184796 DOI: 10.1186/1471-2210-2-17  1
2002 Vicentic A, Robeva A, Rogge G, Uberti M, Minneman KP. Biochemistry and pharmacology of epitope-tagged alpha(1)-adrenergic receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 302: 58-65. PMID 12065700 DOI: 10.1124/jpet.302.1.58  1
2001 Pupo AS, Minneman KP. Adrenergic pharmacology: focus on the central nervous system. Cns Spectrums. 6: 656-62. PMID 15520613  1
2001 Minneman KP. Splice variants of G protein-coupled receptors. Molecular Interventions. 1: 108-16. PMID 14993330  1
2001 Zhong H, Lee D, Robeva A, Minneman KP. Signaling pathways activated by alpha1-adrenergic receptor subtypes in PC12 cells. Life Sciences. 68: 2269-76. PMID 11358336 DOI: 10.1016/S0024-3205(01)01015-3  1
2000 Minneman KP, Lee D, Zhong H, Berts A, Abbott KL, Murphy TJ. Transcriptional responses to growth factor and G protein-coupled receptors in PC12 cells: comparison of alpha(1)-adrenergic receptor subtypes. Journal of Neurochemistry. 74: 2392-400. PMID 10820200 DOI: 10.1046/j.1471-4159.2000.0742392.x  1
2000 Zhong H, Murphy TJ, Minneman KP. Activation of signal transducers and activators of transcription by alpha(1A)-adrenergic receptor stimulation in PC12 cells. Molecular Pharmacology. 57: 961-7. PMID 10779380  1
2000 Berts A, Minneman KP. Tyrosine kinase inhibitors and Ca2+ signaling: direct interactions with fura-2. European Journal of Pharmacology. 389: 35-40. PMID 10686293 DOI: 10.1016/S0014-2999(99)00854-7  1
2000 Zhong H, Minneman KP. Use and pharmacological analysis of established and transfected cell lines expressing adrenergic receptors. Methods in Molecular Biology (Clifton, N.J.). 126: 221-34. PMID 10685414  1
1999 Zhong H, Minneman KP. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells. The Biochemical Journal. 344: 889-94. PMID 10585878 DOI: 10.1042/0264-6021:3440889  1
1999 Guerrero SW, Minneman KP. Coupling efficiencies of beta 1- and beta 2-adrenergic receptors expressed alone or together in transfected GH3 pituitary cells. The Journal of Pharmacology and Experimental Therapeutics. 290: 980-8. PMID 10454468  1
1999 Zhong H, Minneman KP. Alpha1-adrenoceptor subtypes. European Journal of Pharmacology. 375: 261-76. PMID 10443582 DOI: 10.1016/S0014-2999(99)00222-8  1
1999 Zhong H, Minneman KP. Differential activation of mitogen-activated protein kinase pathways in PC12 cells by closely related alpha1-adrenergic receptor subtypes. Journal of Neurochemistry. 72: 2388-96. PMID 10349848 DOI: 10.1046/j.1471-4159.1999.0722388.x  1
1999 Berts A, Zhong H, Minneman KP. No role for Ca++ or protein kinase C in alpha-1A adrenergic receptor activation of mitogen-activated protein kinase pathways in transfected PC12 cells. Molecular Pharmacology. 55: 296-303. PMID 9927621  1
1998 Williams NG, Zhong H, Minneman KP. Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. The Journal of Biological Chemistry. 273: 24624-32. PMID 9733758 DOI: 10.1074/jbc.273.38.24624  1
1997 McCullough JR, Aberg G, Smith ER, Minneman KP. The binding of doxazosin and its enantiomers to α1-adrenoceptor subtypes Pharmacology Communications. 9: 191-196.  1
1996 Theroux TL, Esbenshade TA, Peavy RD, Minneman KP. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Molecular Pharmacology. 50: 1376-87. PMID 8913370  1
1996 Zhong H, Guerrero SW, Esbenshade TA, Minneman KP. Inducible expression of beta 1- and beta 2-adrenergic receptors in rat C6 glioma cells: functional interactions between closely related subtypes. Molecular Pharmacology. 50: 175-84. PMID 8700111  1
1996 Theroux TL, Esbenshade TA, Minneman KP. α1-Adrenergic Receptor Subtypes and Signal Transduction Pharmacochemistry Library. 24: 121-133. DOI: 10.1016/S0165-7208(96)80011-0  1
1995 Guerrero SW, Zhong H, Minneman KP. Selective desensitization of beta 1- and beta 2-andrenergic receptors in C6 glioma cells. Effects on catecholamine responsiveness. Receptor. 5: 185-95. PMID 8840397  1
1995 Zhong H, Minneman KP. Coexisting beta-1 and beta-2-adrenergic receptors with differential receptor reserves in rat C6 glioma cells. The Journal of Pharmacology and Experimental Therapeutics. 272: 1088-94. PMID 7891320  1
1995 García-Sáinz JA, Romero-Avila MT, Villalobos-Molina R, Minneman KP. Alpha 1-adrenoceptor subtype selectivity of tamsulosin: studies using livers from different species. European Journal of Pharmacology. 289: 1-7. PMID 7781702  1
1995 Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman KP, Murphy TJ. Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Molecular Pharmacology. 47: 977-85. PMID 7746284  1
1995 Esbenshade TA, Wang X, Williams NG, Minneman KP. Inducible expression of alpha 1B-adrenoceptors in DDT1 MF-2 cells: comparison of receptor density and response. European Journal of Pharmacology. 289: 305-10. PMID 7621904 DOI: 10.1016/0922-4106(95)90108-6  1
1995 Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RR. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacological Reviews. 47: 267-70. PMID 7568329  1
1995 Adolfo García-Sáinz J, Romero-Avila MT, Villalobos-Molina R, Minneman KP. α1-Adrenoceptor subtype selectivity of tamsulosin: Studies using livers from different species European Journal of Pharmacology: Molecular Pharmacology. 289: 1-7. DOI: 10.1016/0922-4106(95)90161-2  1
1995 Han C, Hollinger S, Theroux TL, Esbenshade TA, Minneman KP. 3H-tamsulosin binding to cloned α1-adrenergic receptor subtypes expressed in human embryonic kidney 293 cells: Antagonist potencies and sensitivity to alkylating agents Pharmacology Communications. 5: 117-126.  1
1995 Ebenshade TA, Minneman KP. Signal transduction by α1-adrenergic receptor subtypes in continuous cell lines Pharmacology Communications. 6: 39-45.  1
1994 Esbenshade TA, Theroux TL, Minneman KP. Increased voltage-dependent calcium influx produced by alpha 1B-adrenergic receptor activation in rat medullary thyroid carcinoma 6-23 cells. Molecular Pharmacology. 45: 591-8. PMID 8183237  1
1994 Minneman KP, Esbenshade TA. Alpha 1-adrenergic receptor subtypes. Annual Review of Pharmacology and Toxicology. 34: 117-33. PMID 8042847 DOI: 10.1146/annurev.pa.34.040194.001001  1
1994 Minneman KP, Theroux TL, Hollinger S, Han C, Esbenshade TA. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Molecular Pharmacology. 46: 929-36. PMID 7969082  1
1994 Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacological Reviews. 46: 121-36. PMID 7938162  1
1994 Esbenshade TA, Minneman KP. Adrenergic Receptor Subtypes: Pharmacological Approaches Neuroprotocols. 4: 2-13. DOI: 10.1006/ncmn.1994.1002  1
1994 Miranda HF, Ramirez H, Castillo O, Minneman KP, Pinardi G. α(1A)-Adrenergic receptors in the isolated human prostate Pharmacology Communications. 4: 181-188.  1
1993 Esbenshade TA, Han C, Murphy TJ, Minneman KP. Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines. Molecular Pharmacology. 44: 76-86. PMID 8393524  1
1993 Minneman KP, Esbenshade TA, Zhong H. Interactions between co-existing beta-adrenoceptor subtypes in continuous cell lines. Biochemical Society Transactions. 21: 1109-14. PMID 8131909  1
1993 Zhong H, Minneman KP. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness. Molecular Pharmacology. 44: 1085-93. PMID 7903414  1
1993 Esbenshade TA, Han C, Minneman KP. [3H]prazosin does not distinguish α1-adrenoceptor subtypes in rat tissues Pharmacology Communications. 3: 323-332.  1
1992 Atkinson BN, Minneman KP. Occupancy-response relationships for beta- and alpha 2-adrenergic receptors exerting opposing effects on cAMP production. Receptor. 2: 195-206. PMID 1361869  1
1992 Esbenshade TA, Han C, Theroux TL, Granneman JG, Minneman KP. Coexisting beta 1- and atypical beta-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Molecular Pharmacology. 42: 753-9. PMID 1359396  1
1992 Han C, Esbenshade TA, Minneman KP. Subtypes of alpha 1-adrenoceptors in DDT1 MF-2 and BC3H-1 clonal cell lines. European Journal of Pharmacology. 226: 141-8. PMID 1353451 DOI: 10.1016/0922-4106(92)90175-U  1
1992 Atkinson BN, Minneman KP. Preferential desensitization of beta- versus alpha 2-adrenergic receptors accelerates loss of response to norepinephrine in primary glial cultures. Molecular Pharmacology. 41: 688-94. PMID 1349153  1
1992 Minneman KP, Esbenshade TA, Han C. Subtypes of alpha-adrenoceptors in contraction of vascular smooth muscle. Japanese Journal of Pharmacology. 58: 128P-134P. PMID 1324334  1
1991 Holtzman SG, Mante S, Minneman KP. Role of adenosine receptors in caffeine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 256: 62-8. PMID 1846425  1
1991 Mante S, Minneman KP. The alkylating prazosin analog SZL 49 inactivates both alpha 1A- and alpha 1B-adrenoceptors. European Journal of Pharmacology. 208: 113-7. PMID 1686864 DOI: 10.1016/0922-4106(91)90061-L  1
1991 Han CD, Minneman KP. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor binding sites in rat tissues. Molecular Pharmacology. 40: 531-8. PMID 1681417  1
1991 Minneman KP, Atkinson B. Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor-mediated second messenger responses in rat brain. Molecular Pharmacology. 40: 523-30. PMID 1681416  1
1991 Wilson KM, Minneman KP. Synergistic interactions between alpha 1- and alpha 2-adrenergic receptors in activating 3H-inositol phosphate formation in primary glial cell cultures. Journal of Neurochemistry. 56: 953-60. PMID 1671588 DOI: 10.1111/j.1471-4159.1991.tb02014.x  1
1991 Atkinson BN, Minneman KP. Multiple adrenergic receptor subtypes controlling cyclic AMP formation: comparison of brain slices and primary neuronal and glial cultures. Journal of Neurochemistry. 56: 587-95. PMID 1671087  1
1991 Wigginton SA, Minneman KP. Comparison of calcium ionophore and receptor-activated inositol phosphate formation in primary glial cell cultures. European Journal of Pharmacology. 208: 239-47. PMID 1663047 DOI: 10.1016/0922-4106(91)90101-M  1
1990 Mante S, Minneman KP. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain? Molecular Pharmacology. 38: 652-9. PMID 2172772  1
1990 Wilson KM, Minneman KP. Different pathways of [3H]inositol phosphate formation mediated by alpha 1a- and alpha 1b-adrenergic receptors. The Journal of Biological Chemistry. 265: 17601-6. PMID 2170387  1
1990 Wilson KM, Minneman KP. Pertussis toxin inhibits norepinephrine-stimulated inositol phosphate formation in primary brain cell cultures. Molecular Pharmacology. 38: 274-81. PMID 2166906  1
1990 Han CD, Wilson KM, Minneman KP. Alpha 1-adrenergic receptor subtypes and formation of inositol phosphates in dispersed hepatocytes and renal cells. Molecular Pharmacology. 37: 903-10. PMID 2163016  1
1990 Wilson KM, Gilchrist S, Minneman KP. Comparison of alpha 1-adrenergic receptor-stimulated inositol phosphate formation in primary neuronal and glial cultures. Journal of Neurochemistry. 55: 691-7. PMID 1973457  1
1990 Han C, Li J, Minneman KP. Subtypes of alpha 1-adrenoceptors in rat blood vessels. European Journal of Pharmacology. 190: 97-104. PMID 1963852 DOI: 10.1016/0014-2999(90)94116-F  1
1990 Mante S, Minneman KP. Caffeine inhibits forskolin-stimulated cyclic AMP accumulation in rat brain. European Journal of Pharmacology. 175: 203-5. PMID 1690138 DOI: 10.1016/0014-2999(90)90231-T  1
1989 Bazil CW, Minneman KP. Clinical concentrations of volatile anesthetics reduce depolarization-evoked release of [3H]norepinephrine, but not [3H]acetylcholine, from rat cerebral cortex. Journal of Neurochemistry. 53: 962-5. PMID 2760627  1
1989 Bazil CW, Minneman KP. Anaesthetic concentrations of enflurane and methoxyflurane in rat brain in-vivo and in-vitro. The Journal of Pharmacy and Pharmacology. 41: 835-9. PMID 2576445  1
1989 Wilson KM, Minneman KP. Regional variations in alpha 1-adrenergic receptor subtypes in rat brain. Journal of Neurochemistry. 53: 1782-6. PMID 2553865  1
1989 Bazil CW, Minneman KP. Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro. The Journal of Pharmacology and Experimental Therapeutics. 248: 143-8. PMID 2536426  1
1988 Minneman KP. Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+. Pharmacological Reviews. 40: 87-119. PMID 2853370  1
1988 Minneman KP, Han C, Abel PW. Comparison of alpha 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101. Molecular Pharmacology. 33: 509-14. PMID 2835650  1
1988 Minneman KP, Mumford GK, Abel PW. High efficiency coupling of alpha-1 adrenergic receptors to inositol phospholipid metabolism revealed by denervation of rat vas deferens. The Journal of Pharmacology and Experimental Therapeutics. 244: 226-30. PMID 2826769  1
1988 Minneman KP. β-Adrenergic receptor subtypes Isi Atlas of Science: Pharmacology. 2: 334-338.  1
1987 Bazil CW, Raux ME, Yudell S, Minneman KP. Equilibration of halothane with brain tissue in vitro: comparison to brain concentrations during anesthesia. Journal of Neurochemistry. 49: 952-8. PMID 3612133  1
1987 Nasseri A, Minneman KP. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex. Molecular Pharmacology. 32: 655-62. PMID 2891027  1
1987 Han C, Abel PW, Minneman KP. Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine. Molecular Pharmacology. 32: 505-10. PMID 2890094  1
1987 Johnson RD, Iuvone PM, Minneman KP. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 242: 842-9. PMID 2821227  1
1987 Han C, Abel PW, Minneman KP. Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature. 329: 333-5. PMID 2442626 DOI: 10.1038/329333a0  1
1987 Johnson RD, Minneman KP. Differentiation of alpha 1-adrenergic receptors linked to phosphatidylinositol turnover and cyclic AMP accumulation in rat brain. Molecular Pharmacology. 31: 239-46. PMID 2436033  1
1986 Bazil CW, Minneman KP. An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex. Journal of Neurochemistry. 47: 547-53. PMID 3016175  1
1986 May JM, Abel PW, Minneman KP. Regulation of beta-adrenoceptor density and function in rat vas deferens. European Journal of Pharmacology. 122: 221-9. PMID 3011443 DOI: 10.1016/0014-2999(86)90106-8  1
1986 Abel PW, Minneman KP. Alpha-1 adrenergic receptor binding and contraction of rat caudal artery. The Journal of Pharmacology and Experimental Therapeutics. 239: 678-86. PMID 2879031  1
1986 Johnson RD, Minneman KP. Characterization of alpha 1-adrenoceptors which increase cyclic AMP accumulation in rat cerebral cortex. European Journal of Pharmacology. 129: 293-305. PMID 2877887 DOI: 10.1016/0014-2999(86)90439-5  1
1986 Minneman KP, Mowry CB. Interactions of putatively irreversible antagonists with beta 1- and beta 2-adrenergic receptors. Biochemical Pharmacology. 35: 857-64. PMID 2869757 DOI: 10.1016/0006-2952(86)90255-8  1
1985 Fox AW, Juberg EN, May JM, Johnson RD, Abel PW, Minneman KP. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness. The Journal of Pharmacology and Experimental Therapeutics. 235: 715-23. PMID 3001274  1
1985 Sutin J, Minneman KP. Adrenergic beta receptors are not uniformly distributed in the cerebellar cortex. The Journal of Comparative Neurology. 236: 547-54. PMID 2997307 DOI: 10.1002/cne.902360410  1
1985 Abel PW, Fox AW, Minneman KP. Effects of isoxuprine and nylidrin on adrenoreceptors in rat vas deferens. Journal of Autonomic Pharmacology. 5: 213-9. PMID 2997229  1
1985 Johnson RD, Minneman KP. Alpha 1-adrenergic receptors and stimulation of [3H]inositol metabolism in rat brain: regional distribution and parallel inactivation. Brain Research. 341: 7-15. PMID 2994816 DOI: 10.1016/0006-8993(85)91466-0  1
1985 Nasseri A, Barakeh JF, Abel PW, Minneman KP. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors. The Journal of Pharmacology and Experimental Therapeutics. 234: 350-7. PMID 2991496  1
1985 Abel PW, Johnson RD, Martin TJ, Minneman KP. Sympathetic denervation does not alter the density or properties of alpha-1 adrenergic receptors in rat vas deferens. The Journal of Pharmacology and Experimental Therapeutics. 233: 570-7. PMID 2989488  1
1985 Sutin J, Minneman KP. alpha 1- and beta-adrenergic receptors are co-regulated during both noradrenergic denervation and hyperinnervation. Neuroscience. 14: 973-80. PMID 2987756 DOI: 10.1016/0306-4522(85)90269-6  1
1985 May JM, Abel PW, Minneman KP. Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response. Naunyn-Schmiedeberg's Archives of Pharmacology. 331: 324-33. PMID 2869414 DOI: 10.1007/BF00500814  1
1985 Juberg EN, Minneman KP, Abel PW. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 330: 193-202. PMID 2865685 DOI: 10.1007/BF00572434  1
1985 Fox AW, Abel PW, Minneman KP. Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery. European Journal of Pharmacology. 116: 145-52. PMID 2865157 DOI: 10.1016/0014-2999(85)90195-5  1
1985 May JM, Abel PW, Minneman KP. Regulation of β2-adrenergic receptors in rat vas deferens Federation Proceedings. 44: No. 8309.  1
1985 Rinard GA, Minneman KL, Torphy TJ. Variation in β adenergic receptor density determines relaxation and protein kinase activation in airway smooth muscle Federation Proceedings. 44: No. 262.  1
1984 Minneman KP. Dynamics of cell-surface receptors. European Journal of Respiratory Diseases. Supplement. 135: 7-15. PMID 6329811  1
1984 Minneman KP. Receptor thermodynamics. Monographs in Neural Sciences. 10: 20-6. PMID 6321970  1
1984 Minneman KP, Abel PW. Relationship between alpha 1-adrenoceptor density and functional response of rat vas deferens. Studies with phenoxybenzamine. Naunyn-Schmiedeberg's Archives of Pharmacology. 327: 238-46. PMID 6149471 DOI: 10.1007/BF00502456  1
1984 Minneman KP, Johnson RD. Characterization of alpha-1 adrenergic receptors linked to [3H]inositol metabolism in rat cerebral cortex. The Journal of Pharmacology and Experimental Therapeutics. 230: 317-23. PMID 6146710  1
1984 Minneman KP, Abel PW. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Molecular Pharmacology. 25: 56-63. PMID 6143249  1
1984 Minneman KP, Holtzman SG. Morphine dependence and withdrawal without alterations in cerebral beta-adrenergic receptor density. Biochemical Pharmacology. 33: 2331-3. PMID 6087822 DOI: 10.1016/0006-2952(84)90676-2  1
1984 Abel PW, Johnson RD, Martin TJ, Minneman KP. Effect of surgical denervation on α1 adrenergic receptors in rat vas deferens Federation Proceedings. 43: no. 15.  1
1984 May JM, Abel PW, Minneman KP. Characterization of a homogenous population of β2-adrenergic receptors in rat vas deferens: Radioligand binding and functional response Federation Proceedings. 43: no. 2684.  1
1984 Minneman KP, Abel PW. Binding and functional properties of α1-adrenergic receptors in rat caudal artery Federation Proceedings. 43: no. 399.  1
1983 Minneman KP. Phenoxybenzamine is more potent in inactivating alpha 1- than alpha 2-adrenergic receptor binding sites. European Journal of Pharmacology. 94: 171-4. PMID 6317400 DOI: 10.1016/0014-2999(83)90458-2  1
1983 Minneman KP, Puckett AM, Jensen AD, Rinard GA. Regional variation in beta adrenergic receptors in dog trachea: correlation of receptor density and in vitro relaxation. The Journal of Pharmacology and Experimental Therapeutics. 226: 140-6. PMID 6306221  1
1983 Minneman KP, Wolfe BB, Pittman RN, Molinoff PB. beta-Adrenergic receptor subtypes in rat brain. Advances in Biochemical Psychopharmacology. 36: 73-81. PMID 6305157  1
1983 Minneman KP. Peripheral catecholamine administration does not alter cerebral beta-adrenergic receptor density. Brain Research. 264: 328-31. PMID 6303503 DOI: 10.1016/0006-8993(83)90835-1  1
1983 Minneman KP, Fox AW, Abel PW. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens. Molecular Pharmacology. 23: 359-68. PMID 6300645  1
1983 Minneman KP. Binding properties of alpha-1 adrenergic receptors in rat cerebral cortex: similarity to smooth muscle. The Journal of Pharmacology and Experimental Therapeutics. 227: 605-12. PMID 6140305  1
1982 Minneman KP, Wolfe BB, Molinoff PB. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Research. 252: 309-14. PMID 6295545 DOI: 10.1016/0006-8993(82)90398-5  1
1982 Wolfe BB, Minneman KP, Molinoff PB. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Research. 234: 474-9. PMID 6277437 DOI: 10.1016/0006-8993(82)90890-3  1
1981 Minneman KP, Pittman RN, Yeh HH, Woodward DJ, Wolfe BB, Molinoff PB. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Research. 209: 25-34. PMID 6260307 DOI: 10.1016/0006-8993(81)91169-0  1
1981 Molinoff PB, Weiland GA, Heidenreich KA, Pittman RN, Minneman KP. Interactions of agonists and antagonists with beta-adrenergic receptors. Advances in Cyclic Nucleotide Research. 14: 51-67. PMID 6116391  1
1981 Minneman KP, Pittman RN, Molinoff PB. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annual Review of Neuroscience. 4: 419-61. PMID 6111980 DOI: 10.1146/annurev.ne.04.030181.002223  1
1980 Pittman RN, Minneman KP, Molinoff PB. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. Journal of Neurochemistry. 35: 273-5. PMID 6256478 DOI: 10.1111/j.1471-4159.1980.tb12517.x  1
1980 Minneman KP, Molinoff PB. Classification and quantitation of beta-adrenergic receptor subtypes. Biochemical Pharmacology. 29: 1317-23. PMID 6249311 DOI: 10.1016/0006-2952(80)90424-4  1
1980 Minneman KP, Weiland GA, Molinoff PB. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Molecular Pharmacology. 17: 1-7. PMID 6247636  1
1980 Pittman RN, Minneman KP, Molinoff PB. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Research. 188: 357-68. PMID 6245756 DOI: 10.1016/0006-8993(80)90037-2  1
1980 Hedberg A, Minneman KP, Molinoff PB. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. The Journal of Pharmacology and Experimental Therapeutics. 212: 503-8. PMID 6244386  1
1980 Weiland GA, Minneman KP, Molinoff PB. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Molecular Pharmacology. 18: 341-7. PMID 6110167  1
1979 Sinensky M, Minneman KP, Molinoff PB. Increased membrane acyl chain ordering activates adenylate cyclase. The Journal of Biological Chemistry. 254: 9135-41. PMID 479183  1
1979 Hedberg A, Minneman KP, Molinoff PB. Regional distribution of beta 1- and beta 2-adrenoceptors in the right atrium and left ventricle of the cat and guinea pig heart [proceedings]. British Journal of Pharmacology. 66: 505P. PMID 230883  1
1979 Minneman KP, Hedberg A, Molinoff PB. Comparison of beta adrenergic receptor subtypes in mammalian tissues. The Journal of Pharmacology and Experimental Therapeutics. 211: 502-8. PMID 229209  1
1979 Zahniser NR, Minneman KP, Molinoff PB. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Research. 178: 589-95. PMID 228797 DOI: 10.1016/0006-8993(79)90720-0  1
1979 Minneman KP, Cuello AC. Cyclic nucleotide phosphodiesterase localization in nerve terminals of the rat substantia nigra. Journal of Neurochemistry. 33: 587-91. PMID 224146  1
1979 Hegstrand LR, Minneman KP, Molinoff PB. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. The Journal of Pharmacology and Experimental Therapeutics. 210: 215-21. PMID 222893  1
1979 Minneman KP, Hegstrand LR, Molinoff PB. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Molecular Pharmacology. 16: 34-46. PMID 39246  1
1979 Minneman KP, Hegstrand LR, Molinoff PB. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Molecular Pharmacology. 16: 21-33. PMID 39243  1
1979 Weiland GA, Minneman KP, Molinoff PB. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature. 281: 114-7. PMID 38405 DOI: 10.1038/281114a0  1
1979 Minneman KP, Dibner MD, Wolfe BB, Molinoff PB. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science (New York, N.Y.). 204: 866-8. PMID 35829  1
1979 Hedberg A, Minneman KP, Molinoff PB. Differential distribution of β1- and β2-adrenoceptors in cat and guinea pig heart Acta Physiologica Scandinavica. 107: No. 51.  1
1979 Minneman KP, Wolfe BB, Dibner MD, Molinoff PB. β-1 and β-2-adrenergic receptors in rat cerebral cortex have different endogenous inputs Federation Proceedings. 38: No. 1922.  1
1978 Minneman KP, Quik M, Emson PC. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection. Brain Research. 151: 507-21. PMID 27287 DOI: 10.1016/0006-8993(78)91083-1  1
1977 Smith JA, Padwick D, Mee TJ, Minneman KP, Bird ED. Synchronous nyctohemeral rhythms in human blood melatonin and in human post-mortem pineal enzyme. Clinical Endocrinology. 6: 219-25. PMID 856506  1
1977 Minneman KP. Postsynaptic induction of serotonin N-acetyltransferase activity and the control of cyclic nucleotide metabolism in organ cultures of the rat pineal. Molecular Pharmacology. 13: 735-45. PMID 196176  1
1977 Minneman KP, Iversen LL. Morphine selectively blocks dopamine-stimulated cyclic AMP formation in rat neostriatal slices [proceedings]. British Journal of Pharmacology. 59: 480P-481P. PMID 191131  1
1977 Kelly PH, Joyce EM, Minneman KP, Phillipson OT. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals. Brain Research. 122: 382-7. PMID 189878 DOI: 10.1016/0006-8993(77)90307-9  1
1977 Smith JA, Spokes EG, Bird ED, Minneman KP. Human post-mortem pineal metabolism. Lancet. 2: 930-1. PMID 72270 DOI: 10.1016/S0140-6736(77)90865-0  1
1976 Minneman KP. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties. Journal of Neurochemistry. 27: 1181-9. PMID 12170605  1
1976 Minneman KP. Cyclic nucleotide phosphodiesterase in rat neostriatum: properties of the enzyme in crude homogenates. Journal of Neurochemistry. 27: 1173-80. PMID 12170604  1
1976 Minneman KP, Iversen IL. Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum. Nature. 262: 313-4. PMID 183126 DOI: 10.1038/262313a0  1
1976 Minneman KP, Wurtman RJ. The pharmacology of the pineal gland. Annual Review of Pharmacology and Toxicology. 16: 33-51. PMID 180879 DOI: 10.1146/annurev.pa.16.040176.000341  1
1976 Minneman KP, Iversen LL. Cholera toxin induces pineal enzymes in culture. Science (New York, N.Y.). 192: 803-5. PMID 178053  1
1976 Minneman KP, Iversen LL. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity. Nature. 260: 59-61. PMID 177878 DOI: 10.1038/260059a0  1
1975 Minneman KP, Wurtman RJ. Effects of pineal compounds on mammals. Life Sciences. 17: 1189-99. PMID 1105043 DOI: 10.1016/0024-3205(75)90127-7  1
1974 Minneman KP, Lynch H, Wurtman RJ. Relationship between environmental light intensity and retina-mediated suppression of rat pineal serotonin-N-acetyl-transferase. Life Sciences. 15: 1791-6. PMID 4620990 DOI: 10.1016/0024-3205(74)90180-5  1
Show low-probability matches.